MPM Bioventures 2018 (b), L.P., 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 45,792 shares at $35.49 ($1.6M) on 2021-11-26, disclosed to the SEC on 2021-11-30.
Scheduled sale ($1.6M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.49 | 6,545 | $232K | 14.4% |
| 2 | $35.49 | 6,545 | $232K | 14.4% |
| 3 | $36.03 | 6,129 | $221K | 13.7% |
| 4 | $36.03 | 6,129 | $221K | 13.7% |
| 5 | $34.46 | 10,073 | $347K | 21.5% |
| 6 | $34.46 | 10,073 |
| $347K |
| 21.5% |
| 7 | $35.37 | 298 | $11K | 0.7% |
| Total | $35.18 avg | 45,792 | $1.6M | 100% |
| Filing → |
| ITOS | SELL | 2021-09-08 | $2.4M | — | Filing → |